Brieflands
Journal finderSearch
·
Sign in

Innovative Journal of Pediatrics

The Scientific Journal of Growth & Development Research Center

e-ISSN 3117-5341
Home
Articles
    Accepted ManuscriptsCurrent IssueAll IssuesIn Press ArticlesSearch
Instructions
About Journal
    Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Innovative Journal of Pediatrics
  6. /
  7. Articles
  8. /
  9. BLES Versus Curosurf for Treatment of Respiratory Distress in Preterm Neonates and Their Adverse Effects
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated September 16, 2026
← Back to article
1

Curosurf Versus BLES in the Treatment of Preterm Neonates with Respiratory Distress Syndrome: A Randomized Clinical Trial

Innovative Journal of Pediatrics

June 2025

Ostadmohammadi V.

Open Access

2

A systematic scoping review of the use of surfactant replacement therapy for respiratory distress syndrome in preterm neonates in low- and middle-income countries

Frontiers in Pediatrics

2025

Price C.A.

Open Access

3

Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome

Plos One

June 2023

Izadi R.

Open Access

4

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress

Plos One

June 2022

Jahanmehr N.

Open Access

5

Poractant alfa versus bovine lipid extract surfactant: prospective comparative effectiveness study

Journal of Perinatology

April 2022

Lemyre B.

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.